Related Experiment Video

Updated: Mar 18, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

3.7K

The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury

Linda Sevelsted Møller1,2, Annette Dam Fialla1, Robert Schierwagen3

  • 1Department of Medical Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.

Scientific Reports
|June 30, 2016
PubMed

Insights

The calcium-activated potassium channel KCa3.1 plays a protective role in liver injury, contrary to previous findings. Inhibition of KCa3.1 exacerbates liver fibrosis and increases hepatocyte damage.

Area of Science:

  • Cellular Biology
  • Physiology
  • Hepatology

Background:

  • The calcium-activated potassium channel KCa3.1 regulates cellular functions like proliferation and volume.
  • Its role in liver fibrosis, particularly in hepatocytes, remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of KCa3.1 in experimental and human liver fibrosis.
  • To determine the effects of KCa3.1 genetic depletion and pharmacological inhibition on liver injury.

Main Methods:

  • KCa3.1 gene and protein expression analyzed via RT-PCR, Western blot, and immunohistochemistry.
  • In vivo studies using carbon tetrachloride-induced liver fibrosis in mice and hemodynamic assessments in rats.
  • In vitro experiments on rat hepatic stellate cells and hepatocytes.

Main Results:

  • KCa3.1 expression is upregulated in rodent and human liver fibrosis, primarily in hepatocytes.
  • KCa3.1 inhibition worsened liver fibrosis and increased hepatocyte apoptosis and DNA damage.
  • KCa3.1 inhibition stimulated hepatic stellate cell proliferation but did not alter hemodynamic parameters in portal hypertensive rats.

Conclusions:

  • KCa3.1 channels are crucial modulators of hepatocellular homeostasis.
  • Contrary to in vitro and other tissue findings, KCa3.1 exhibits anti-fibrotic and protective effects during liver injury.

More Related Videos

Patch Clamp and Perfusion Techniques for Studying Ion Channels Expressed in Xenopus oocytes10:19

Patch Clamp and Perfusion Techniques for Studying Ion Channels Expressed in Xenopus oocytes

Published on: January 10, 2011

21.9K
Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

2.7K

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
7.0K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
904
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
12.7K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.5K